Wieman Stephanie M, Landercasper Jeffrey, Johnson Jeanne M, Ellis Richard L, Wester Susan M, Lambert Pamela J, Ross Lauren A
Department of General Surgery, Norma J. Vinger Center for Breast Care (NJVCBV), the Gundersen Lutheran Health System, La Crosse, Wisconsin 54601, USA.
Am Surg. 2008 Dec;74(12):1211-4.
Tumoral pseudoangiomatous stromal hyperplasia (PASH) is a rare benign proliferative disease of the breast. The majority of the literature reports of PASH have not contained detailed descriptions of the imaging characteristics of PASH. A 10-year retrospective study of patients with tumoral PASH and a 20-year Ovid MEDLINE search were performed to determine whether specific imaging and needle biopsy results could characterize PASH preoperatively. We identified 22 patients with tumoral PASH. Seventeen (77%) of 22 women had a palpable lump and 14 (72%) of 21 had a density on mammography. Ultrasound (US) findings included mixed or hypoechoic echogenicity in 83 per cent and ill-defined borders in 62 per cent. Eight (36%) patients had lesions with a Breast Imaging Reporting and Data System (BI-RADS) classification of 4 or 5. The sensitivity of preoperative core needle biopsy (CNB) to identify PASH was 83 per cent. A review of the literature revealed that 90 per cent of patients with PASH had some malignant imaging characteristics and 95 per cent had a mass on mammography. The imaging characteristics of PASH exhibited marked variability. Excision of PASH after CNB may be considered for patients with symptoms, enlarging lesions, or lesions classified as BI-RADS 4 or 5. PASH diagnosed by CNB allows selected patients to avoid excision.
肿瘤性假血管瘤样间质增生(PASH)是一种罕见的乳腺良性增生性疾病。大多数关于PASH的文献报道都没有对其影像学特征进行详细描述。我们进行了一项针对肿瘤性PASH患者的10年回顾性研究,并在Ovid MEDLINE上进行了20年的检索,以确定特定的影像学和针吸活检结果是否能够在术前对PASH进行特征性诊断。我们共纳入了22例肿瘤性PASH患者。22名女性中有17名(77%)可触及肿块,21名中有14名(72%)在乳腺钼靶检查中有密度影。超声(US)检查结果显示,83%的病变为混合回声或低回声,62%的病变边界不清。8名(36%)患者的病变根据乳腺影像报告和数据系统(BI-RADS)分类为4类或5类。术前粗针穿刺活检(CNB)诊断PASH的敏感性为83%。文献回顾显示,90%的PASH患者具有一些恶性影像学特征,95%的患者在乳腺钼靶检查中有肿块。PASH的影像学特征表现出明显的变异性。对于有症状、病变增大或分类为BI-RADS 4类或5类的患者,可考虑在CNB后切除PASH。通过CNB诊断为PASH的部分患者可避免手术切除。